Efficacy News and Research

RSS

Study shows survival benefit of home-based rehabilitation in cardiovascular disease patients

In a recent study published in the Journal of the American Heart Association, researchers comparatively evaluated death rates among home-based cardiac rehabilitation (HBCR) participants and non-participants.

5 Mar 2023

Transcatheter-based mitral valve repair safe and effective for nearly 9 out of 10 patients

The largest study to examine outcomes for patients treated outside a clinical trial setting with a minimally invasive procedure to repair a poorly functioning mitral valve in the heart found that the procedure was safe and resulted in a successful repair for nearly 9 out of 10 patients, researchers reported at the American College of Cardiology's Annual Scientific Session Together With the World Congress of Cardiology. Patients whose procedure was successful were half as likely to die within one year compared with those in whom the procedure was unsuccessful.

5 Mar 2023

Therapeutic ketosis for mild cognitive impairment, Alzheimer's and Parkinson's

A new study in Frontiers in Neurology aimed to review the available studies which support the clinical utility of ketogenic interventions in PD, MCI, and AD.

5 Mar 2023

Naked mRNA delivered using needle-free PYRO injection presents a safe and effective potential vaccination method

Researchers examined the vaccination effects and local antigen expression efficiency of a needle-free vaccination technique involving pyro-drive liquid jet injection (PYRO) to deliver the naked messenger ribonucleic acid (mRNA) to the skin.

3 Mar 2023

UK HealthCare neurologist helps to compile an essential list of MS medications

Together with Multiple Sclerosis (MS) experts, biostatisticians and clinicians from across the globe, a UK HealthCare neurologist has helped compile an essential list of MS medications for patients in resource-poor settings.

3 Mar 2023

Study identifies the essential genetic and immunologic perturbations occurring in patients with long COVID lung fibrosis

Researchers elucidated immunologic and genetic perturbations in long COVID patients with pulmonary fibrosis.

3 Mar 2023

Cirrhosis associated with lower immune responses to COVID-19 vaccines in patients with chronic liver disease

The overall responsiveness of patients with chronic liver disease (CLD) to COVID-19 vaccines has been shown to be decreased in patients with cirrhosis.

2 Mar 2023

What factors impacted the adoption of self-management behavior of patients with chronic kidney disease during COVID-19?

Researchers assessed the self-management practices of chronic kidney disease patients during the COVID-19 pandemic.

2 Mar 2023

SARS-CoV-2 BA.1 and BA.2 breakthrough infections likely protect against BA.4 infection

Omicron BTIs induce durable neutralizing immune responses by recalling cross-reactive and vaccine-induced memory B lymphocytes.

1 Mar 2023

Exploring the neuroprotective potential of cell-penetrating peptides, extracellular vesicles, and micro ribonucleic acids

In a recent review published in Biomedicines, researchers explored extracellular vesicles (EVs), cell-penetrating peptides (CPPs), and micro ribonucleic acids (miRNAs) as therapies for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD).

1 Mar 2023

What is the role of B cells in breast cancer pathology?

In a recent study published in Cancers, researchers comprehensively summarized all available information about B cells in the context of breast cancer.

1 Mar 2023

New imaging method could help make better decisions on personalized cancer treatment

Decisions on cancer treatment could become better tailored to individual patients with the adoption of a new imaging method being developed by University of Michigan researchers that maps the chemical makeup of a patient’s tumor.

1 Mar 2023

Breaking apart certain proteins may offer a pathway to treat Alzheimer's diease

Certain diseases, including Alzheimer's, are currently considered "undruggable" because traditional small molecule drugs can't interfere with the proteins responsible for the illnesses.

1 Mar 2023

Covid-19 vaccination can curb the effect of long COVID on patients' social, professional, and family lives

Vaccination against SARS-CoV-2, the virus responsible for COVID-19, may lessen the severity and duration of 'long COVID' in those with persistent symptoms after infection, suggests a study that closely imitates a randomized clinical trial, and published in the open access journal, BMJ Medicine.

1 Mar 2023

Efficacy News and Research

Study shows survival benefit of home-based rehabilitation in cardiovascular disease patients

Transcatheter-based mitral valve repair safe and effective for nearly 9 out of 10 patients

Therapeutic ketosis for mild cognitive impairment, Alzheimer's and Parkinson's

Naked mRNA delivered using needle-free PYRO injection presents a safe and effective potential vaccination method

UK HealthCare neurologist helps to compile an essential list of MS medications

Study identifies the essential genetic and immunologic perturbations occurring in patients with long COVID lung fibrosis

Cirrhosis associated with lower immune responses to COVID-19 vaccines in patients with chronic liver disease

What factors impacted the adoption of self-management behavior of patients with chronic kidney disease during COVID-19?

SARS-CoV-2 BA.1 and BA.2 breakthrough infections likely protect against BA.4 infection

Exploring the neuroprotective potential of cell-penetrating peptides, extracellular vesicles, and micro ribonucleic acids

What is the role of B cells in breast cancer pathology?

New imaging method could help make better decisions on personalized cancer treatment

Breaking apart certain proteins may offer a pathway to treat Alzheimer's diease

Covid-19 vaccination can curb the effect of long COVID on patients' social, professional, and family lives

Product development and drug delivery at Seda

Genome editing techniques based on bacterial-artificial-chromosome in herpesvirus research

New funding to accelerate development of potential anti-cancer compound into the clinic

St. Jude researchers show how drug makers can avoid toxicity and resistance

Inexpensive combo-chemotherapy found to be better tolerated than BCG for common bladder cancer

CN Bio extends microphysiological system portfolio with PhysioMimix Single-Organ Higher Throughput System

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News